Company · CIK 0001750284 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Olema Pharmaceuticals, Inc. · OLMA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 23, 2026 SForm 4 → | Jul 27, 7:30 pm EDT | Cyrus HarmonDirector | 25,000 | $11.65 | $291,163 | 702,770 | −3.44% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 AForm 4 → | Sep 2, 4:30 pm EDT | Jason O'ByrneCHIEF FINANCIAL OFFICER | 650,000 | — | — | 650,000 | — | |
| Jun 18, 2026 AForm 4 → | Jun 23, 5:52 pm EDT | BVF PARTNERS L P/IL +9Director | 29,500 | — | — | 29,500 | — | |
| Jun 18, 2026 AForm 4 → | Jun 23, 5:30 pm EDT | Cyrus HarmonDirector | 29,500 | — | — | 29,500 | — | |
| Jun 18, 2026 AForm 4 → | Jun 23, 5:29 pm EDT | Cynthia M ButittaDirector | 29,500 | — | — | 29,500 | — | |
| Jun 18, 2026 AForm 4 → | Jun 23, 5:28 pm EDT | J. Scott GarlandDirector | 29,500 | — | — | 29,500 | — | |
| Jun 18, 2026 AForm 4 → | Jun 23, 5:27 pm EDT | Gorjan HrustanovicDirector | 29,500 | — | — | 29,500 | — | |
| Jun 18, 2026 AForm 4 → | Jun 23, 5:26 pm EDT | Ian T ClarkDirector | 29,500 | — | — | 29,500 | — | |
| Jun 18, 2026 AForm 4 → | Jun 23, 5:25 pm EDT | Yi LarsonDirector | 29,500 | — | — | 29,500 | — | |
| Jun 18, 2026 AForm 4 → | Jun 23, 5:24 pm EDT | Sandra HorningDirector | 29,500 | — | — | 29,500 | — | |
| Jun 18, 2026 AForm 4 → | Jun 23, 5:23 pm EDT | Prakash RamanDirector | 29,500 | — | — | 29,500 | — | |
| Jun 18, 2026 AForm 4 → | Jun 23, 5:22 pm EDT | Andrew RappaportDirector | 29,500 | — | — | 29,500 | — | |
| Jun 18, 2026 AForm 4 → | Jun 23, 5:21 pm EDT | G. Walmsley GrahamDirector | 29,500 | — | — | 29,500 | — |